




health services. They play an important 
role in such matter,;; as the recruitment 
of blood donors, persuading patients to 
attend regularly for check-ups and treat-
ment, giving group talks on public health 
questions at places of work, in parks, on 
housing estates, etc., distributing health 
propaganda leaflets, and generally assist-
ing the public health authorities in every 
possible way. 
Every year the Soviet Ministry of 
Health organizes a Public Health Day on 
the same lines as the World Health Orga-
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nization's World Health Day. A particular 
aspect of public health is chosen as the 
central theme and a programme of acti-
vities is worked out starting some months 
before and culminating on Public Health 
Day. The programme includes talks and 
discussions over the radio and television, 
in schools, at health centres, article$ in 
the press, specially prepared feature films 
in cinemas, etc. The great interest shown 
by the people at large and the success of 
this yearly venture are due, by and large, 
to the work of the health volunteers. 
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The recent interest in transplantation 
of organs is largely due to the technical 
advances in surgical procedures making it 
possible to replace organs in the human, 
as well as to an increased understanding 
of the basic biological problems under-
lying the rejection of such grafts. More-
over, the therapeutic armamentarium 
which can to a certain extent suppress 
such immunological reaction has been 
greatly increased in recent years. 
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At this first International Congress 
widely ranging topics were discussed, in-
cluding organ transplantation, mechanism 
of graft rejection, methods of immuno-
suppression, genetics of transplantation, 
bone marrow transplantation, and finally, 
cancer as homograft. It would be quite 
impossible in this brief communication to 
do more than give an outline of some of 
the papers presented. Further details can 
be obtained from the compendium of ab-
stracts of paper*, and from the more com-
* A copy of these Astracts can be obta:ned 
from the Medical Library, St. Luke's Hospital. 
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prehensive book giving the actual papers, 
to be published in the near future. 
A. Organ Transplantation 
1. Kidney Transplantation 
It is only natural to expect that kidney 
transplantation would receive a lot of at-
tention. Thanks to the Human Kidney 
Transplant Registry (Murray et al. Boston, 
USA) more than 1200 kidney transplanta-
tions have been recorded, and the various 
factors which influence survival can be 
compared. It was shown that 75% of kid-
neys from parents or siblings, and 60% of 
grafts from living donors or cadavers 
(unrelated) were still functional one year 
after transplantat. This represents a con-
siderable improvement over previous re-
ports. (A more detailed study appears in 
the July issue of "Transplantation"). In a 
personal communication J. E. Murray 
stated that survival of parental kidney 
grafts at 18 months is 49% and at 24 
months is 43.%. 
Immunosuppressive therapy plays an 
important part in preventing rejections of 
homografts. Sheil et al. (Boston, USA) 
reported that in dogs the expected life of 
a grafted kidney can be increased three-
fold by such means. Kountz& Cohn (Palo 
Alto, USA) indicated that injection of these 
drugs into the graft was a better way of 
preventing graft rejection than either oral 
or parenteral administration. 
The development of micro-surgical 
techniques enabled the transplantation of 
kidneys in small laboratory animals such 
as the rat. This is important because the 
rat is the largest animal which is readily 
available in highly inbred strains, so that 
comparison between isografts and homo-
grafts could be made. Using such a tech-
nique Lindquist et al. (Boston, USA) found 
that two days after transplantation mono-
nuclear cells were present in the peri-
tubular capillaries and some adhered to 
the vascular epithelium. IgG was localised 
on the walls of many peritubular capilla-
ries and in vein walls. Beta lc globulin, 
but not fibrinogen or alpha 2 macroglobu-
lin was present. IgM was not found. 
Changes in the glomerular architecture 
included endothelial cell swelling and pro-
liferation, mesangial swelling and some 
basement membrane thickening. Perivas-
cular infiltration of mononuclear cells with 
large vesicular nuclei, prominent nucleoli 
and pyroninophilic cytoplasm appeared 
2"3 days after allografting and infiltrated 
the cortex diffusely by the 5th day. 
It is essential to be able to detect 
rejection as early as possible so that suit-
able therapy can be instituted. Spencer and 
Posborg-Petersen (Aarhus, Denmark) sug-
gested that the quantitative determination 
of urinary lymphocytes excretion was a 
valuable aid in the management of patients 
with renal transplants. With clear-cut re-
jection episodes the number of lympho-
cytes was more than 25,OOO/hour, and 
these lymphocytes disappeared from the 
urine on initiation and maintenance of ade-
quate steroid therapy. Likewise 13ll hip-
pur an renography performed daily in dogs 
subjected to renal allografts showed after 
2-7 days a continuous decrease of excre-
tory capacity which finally resulted in a 
renogram of the obstructive type. This 
was shown by 125I hippuran auto-radio-
graphy to be due to ischcemia and net to 
obstruction by cedema (Lundgren et at. 
Stockholm, Sweden). 
The problem of glomerulonephritis in 
the transplanted kidney was discussed by 
Feldman et al. (Boston, USA) and Ham-
burger et al. (Paris), and the nephrotic 
syndrome was described by Williams et al. 
(Richmond, USA). As pointed out by Mer-
rill (Boston, USA) these incidents provide 
rare examples of disordered physiology 
that could only be studied in the setting 
of human transplantation, and could pro-
vide answers to problems about the rela-
tionship between the kidney and hyper-
tension, erythropoiesis, etc. 
2. Liver Transplantation 
The problems of liver transplantation, 
although technically more formidable than 
renal grafting, are not insurmountable, 
and this procedure was described in pigs, 
dogs, and rats. Liver homotransplantation 
was described in pigs by Riddell et al. 
(Bristol, Eng.). The histological picture of 
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rejection of the transplant was described. 
The use of antilymphotic serum (ALS) 
was mentioned as of possible therapeutic 
importance. A whole session was devoted 
to the mode of action and use of ALS and 
will be described later. Cockburn et al. 
(Boston, USA) described a method of 
transplanting fresh or preserved liver 
heterotopically in the pelvis of the rat. 
About 30% of a donor rat liver was trans-
planted. Shorter et al. (Rochester USA) in 
transplanting liver in dogs found that 
urinary uric acid levels characteristic of 
the donor animal were found in the reci-
pient dog, thus demonstrating again the 
use of transplantation techniques in the 
study of the physiology of body systems. 
3. Heart Transplantaion 
Shumway (Palo Alto, USA) introduced 
this session by considering the possible 
consequences of heart transplantation. The 
immediate causes for concern he suggest-
ed, were (a) disorders of rhythm - these 
became normal again by 4-5 days, and 
(b) disorders of cardiac output - output 
was normal by 3-4 weeks. Late conse-
quences could be ascribed to disorders of 
sympathetic and parasympathetic inner-
vation. These were usually normal by 3-4 
months, but disorders could occur if sym-
pathetic nerves innervated parasympathe-
tic nerve endings, with obvious malfunc-
tion of the heart itself as well as altered 
drug action (e.g. sympathetic drugs will 
have a parasympathetic action). The tech-
nique was beautifully illustrated by a ten-
minute film which, it seemed, was neces-
sary to make the incredulous believe that 
heart transplantation is actually possible. 
This technique enabled various phy-
siological studies to be undertaken. Lower 
and Celeveland (Richmond, USA) demon-
strated that the denervated heart graft had 
the capacity to increase the cardiac out-
put under a variety of physiological con-
ditions, including hypoxia and exercise. 
Cardiac output was still normal 5! years 
after autograft of the heart. Re-innerva-
tion was unequivocally demonstrated in 
the majority of animals 3-5 months after 
autotransplantation. Similar studies were 
performed by Willman et al. (St. Louis. 
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USA) in dogs and baboons. ECG changes 
after transplantation were studied by 
Dureau et al. (Brooklyn, USA). 
The fact that current surgical tech-
niques were successful in 80-90.% of expe-
riments (Lower and Cleveland, Richmond, 
USA), and that both canine and human 
cadaver hearts have been successfully 
resuscitated after 30 minutes of clinical 
"death", with, in the dog, successful sub-
sequent transplantation after 4-7 hours of 
storage under hypothermia, renders this 
a practical proposition. The fact that heart 
grafts are less easily rejected than kidney 
grafts renders the control of rejection 
crises easier to deal with (Lower and Cle-
veland, USA; Cacher et al. Paris, France). 
4. Lung Transplantation 
The problem of lung transplantation 
was discussed by Blumenstock (Coopers-
town, USA), Hardy et al. (Jackson, USA), 
and Neveux et al. (Paris, France). Lung 
transplantation in 1000 dogs enabled va-
rious physiologic and immunologic studies 
to. be undertaken. There was an immediate 
fall in 02 uptake, blood gas values, pH, 
and pulmonary arterial pressures. These 
gradually improved but there was no 
return of the cough or of the Hering Breuer 
reflex up to 18 months after transplanta-
tion. Lymphatic regeneration could be 
demonstrated within two weeks. With 
homotransplantation, the average survival 
of the allograft was 40 days, with the use 
of mediastinal irradiation, azathioprine 
and steroids, but survival for 2-5 years 
with methotrexate was described by Blu-
menstock. 
5. Pancreas Transplantation 
Two papers by Kelly et al. (Minnea-
polis, USA) and Bergen and Teixera (Chi-
cago, USA) described transplantation of 
the pancreas in dogs and in patients suf-
fering from diabetes mellitus. 
6. Other problems 
A number of o.ther related problems 
were discussed, including the ethics and 
legal aspects of human organ transplan-
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tation (Woodruff, Edinburgh, Scotland; 
Couch, Boston, USA); the use of local 
X-rays in the treatment of kidney trans-
plantation (Kirpatovsky et al., Moscow, 
USSR); the irradiation of lymph nodes 
(Shikata et al., Kyoto, Japan); the use of 
preserved organs (Ackerman et al., Lon-
don, England); the selection of donors for 
kidney transplantation (Dausset et al. 
Paris, France); the presence of hcemagglu-
tinins in human kidney transplant reci-
pients (Rapaport et al. New York, USA); 
the detection of onset of graft rejection by 
immunological methods (Kaskova, Praha, 
Czech.); and the lung complications asso-
ciated with kidney transplantation - a 
condition known as "transplant lung" 
(Slapak et al. Montreal, Canada). 
An interesting and unexpected result 
was the transfer of secondary epidermoid 
carcinoma from a donor who died of this 
condition without evidence of metastasis 
to the kidney (Wilson et al. Boston, USA) 
- a finding which seems to rule out can-
cer patients as prospective donors of 
organs for transplantation. 
It can be seen from the above sum-
mary that surgical techniques are no 
longer the main factor responsible for the 
success of an organ transplant. Much more 
important is a knowledge of the various 
factors which make the graft unacceptable 
to the host, and ways and means of sup-
pressing the immune reaction. These basic 
considerations will be dealt with briefly 
below. 
B. Mechanism of Graft Rejection 
Although Nossal (Melbourne, Austra-
lia) described this as "a golden age of 
immunology" in view of the rapid and 
important advances in this field, we still 
do not fully understand the mechanism 
by which the body recognizes a graft as 
foreign, and then mounts an immunolo-
gical attack on it with subsequent rejec-
tion. It is known that recognition depends 
on the strength of the transplantation 
antigens themselves, as well as on the pre-
sence of an intact immune system which 
involves recognition (afferent) and effector 
(efferent) mechanisms. 
That the graft is immunologically 
immune as long as it has no lymphatiC 
contact with the host was further empha-
sised by Barker and Billingham (Philadel-
phia, USA) who described a technique of 
isolating a flap of skin in guinea pigs so 
that the blood supply was intact, but the 
lymphatics were destroyed. This flap could 
retain grafts as long as the lymphatics 
were absent, indicating that an intact lym-
phatic drainage is essential for rejection 
of skin homografts. 
The production of tolerance of homo-
grafts is a well authenticated phenomenon 
in immunobiology, and can be produced 
in suitable animals by the injection of anti-
genic substances in adequate amounts. 
This can result in grafts surviving for pro-
longed periods. Hasek et al. (Prague, Cze-
choslovakia) produced evidence that serum 
antibody can abolish tolerance and pro-
duce destruction of tolerated skin grafts, 
while Wright (Palo Alto, USA) demon-
strated specific tolerance to H-2 iso-anti-
gens induced by enhancing antibody. Sab-
badini and Sehon (Montreal, Canada) 
showed that RNA extracted from lymph 
nodes of immunised mice can confer im-
munity. Of major significance is the find-
ing of Nossal (Melbourne, Australia) that 
minute quantities of antigen can induce 
tolerance whereas larger quantities pro-
duce immunization - an extension of the 
work of Mitchison (London, England). 
The recent enormous interest in the 
thymus and its role in the immunological 
system was reflected by the number of 
papers presented. Miller and Mitchell 
(Melbourne, Australia) studied the influ-
ence of the thymus on antigen-reactive 
cells and their precursors. They found that 
the proliferation and differentiation of 
such cells are not thymus dependent, but 
require contact with antigen. Tyan et aL 
(San Francisco, USA) found that lymphoid 
"stem" cells in mouse fretal liver were 
thymus dependent by 14 days of gestation. 
Trainin et al. (Rehovot, Israel) showed that 
although thymectomised mice fail to reject 
homografts, and lymphoid cells from such 
animals fail to produce a graft-versus-host 
reaction in Fr hybrid recipients, however, 
lymphoid cells from such animals plus 
thymus extracts were able to produce a 
graft-versus-host reaction. Davies et al. 
(London, England) discussed the role of 
thymus-derived cells in an immune res-
ponse. 
This obviously sketchy account of 
this section is indicative of the intricate 
nature of the problem of the mechanism 
of graft rejection and and of the relation 
of lymphoid tissue, and especially the 
thymus, to this process. 
c. Methods of Immuno-depression 
1. Antilymphocytic Serum (ALS) 
The production of serum active 
against lymphocyte is an important deve-
lopment in the treatment of immune re-
jection phenomena. Woodruff and his 
group (Edinburgh, Scotland) who pio-
neered this form of treatment gave evi-
dence that ALS inhibited skin homograft 
rejection, whereas antibody fragments 
(Fab')z prepared by pepsin digestion of 
anti-lymphocytic immunoglobin did not. 
Lance (Mill Hill, England) observed that 
continuous steady levels of ALS prolonged 
graft survival whereas pulsed doses were 
not so effective. Prent et al. (Southamp-
ton, England) observed that while new-
born mice injected with allogeneic lym-
phoid cells died of graft-versus-host dis-
ease, ALS prevented this if given 6 days 
after the production of GVH. In vitro 
treatment for one hour was highly effect-
ive in suppressing runting. Similar results 
were reported by van der Werf et al. 
(Boston, USA). Boak et al. (Boston, USA) 
gave ALS to donor animals and found that 
cells from such animals had lost the abi-
lity to initiate a GVH reaction when trans-
ferred to a suitable recipient. The survival 
of renal homotransplants in dogs was also 
increased after treatment with ALS (Pilch-
mayr et al Munich, Germany). 
Although toxic manifestations follow-
ing ALS treatment included ancemia, evi-
dence of glomerulophritis, anaphylactic 
shock, as well as the expected lympho-
prenia and lymphocytic depletion of the 
spleen and lymphoid orgfians, (Lance, Mill 
Hill, England), these drawbacks can be 
overcome by purification of the crude 
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ALS and the use of the specific immuno-
globulin fraction. 
2. Chemical Immuno-depression 
Various agents have been used to 
suppress the immunological reaction. 
Cytotoxic and antiproliferative agents in-
clude radiation, purine and pyrimidine 
analogues, alkylating agents, folic acid 
antagonists, methylhydrazine derivatives, 
and antibiotics (actinomycin, mitomycin, 
and puromycin). Steroids of the hydro-
cortisone family probably act in two ways 
(Medawar, London, England): i) the acute 
effect following high doses is largely peri-
pheral, while ii) chronic doses probably 
prolong immunosuppressive action by 
slowing down lymphocyte turnover. Boyl-
ston et al. (London, England) found ribo-
nucleases effective in suppressing a num-
ber of immune responses including rejec-
tion of mouse skin allografts and canine 
renal allografts, if given two days before 
grafting. Changes in the rate of synthesis 
of IgG, IgM and specific antibody were 
always found. 
A knowledge of the mode of action of 
these agents in relation to the cell cycle 
may be important as shown by Amiel and 
Dore (Villejuif, France), who found that 
agents which interfere with DNA synthesis 
(e.g. mitomycin C) exert maximal imffiu 
nodepressive activity when given before 
the antigenic stimulus, whereas alkylating 
agents and methylhydrazines which can 
affect cells not in DNA synthesis suppress 
the immune reaction when given after the 
antigenic stimulus. The cytotoxic action of 
lymphocyles in vitro - which is indepen-
dent of DNA synthesis or of mitosis -
was abolished by antimycin A, iodoacetate, 
2,4-dinitrophenol, while immunosuppres-
sive agents like imuran and cyclophospha-
mide had only weak effect. (Holm and 
Perlman, Stockholm, Sweden). 
Immunosuppression is of great impor-
tance in preventing rejection of grafts. 
The obvious blunderbuss therapy with 
ALS, although effective, will certainly be 
refined to produce fractions which are 
more active and less toxic. It is also pos-
sible, as indicated above, that the use of 
these and similar pharmacological agents 
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will provide further insight into the 
mechanism of graft rejection. 
D. Genetics of Transplantation 
The importance of basic knowledge 
of the factors which make the host diffe-
rent from the graft, and the necessity of 
identifying the most likely donor for pros-
pective graft transplantation, made it im-
perative for techniques to be developed to 
identify as many antigenic sites as pos-
sible. This work, pioneered by Van Rood, 
Ceppelini, Batchelor, Terasaki and others, 
has become of major importance in the 
study of transplantation in general. 
Ceppelini (Turin, Italy) introduced 
this meeting by summarising the recent 
advance in leucocyte typing, indicating 
that "finger-printing" of these antigens is 
now possible. This has become so complex 
in recent years that computer methods 
have been developed to analyse the avail-
able data. Studies of the genetic linkage 
and inheritance of the major loci respon-
sible for histo-compatibility have been 
worked out. These results were discussed 
in a recent "workshop on histo-compati-
bility testing" which took place in Turin 
in June 1967. 
Amos et al. (Durham, USA) described 
the Hu-1 system in man as the strongest 
transplantation system, equivalent to the 
H2 system in mice. Chromosomal inherit-
ance patterns could be easily recognised. 
Van Rood et al. (Leiden, Netherlands) des-
cribed the "Group FOUR system" of trans-
plantation antigens in man, and showed 
that for patients who receive a kidney 
transplant from a sib or a parent, prior 
matching of the leucocyte antigens was 
extremely important for graft survival. 
Rapid methods of leucocyte typing 
were described by Payne et al. (San Fran-
cisco, USA), making use of micro-agglu-
tination technique. Bach (Madison, USA) 
described a method for assay of the major 
histo-compatibility locus in man (Hu-1), 
using a mixed leucocyte culture technique. 
The obvious importance of this sec-
tion of research cannot be adequately dealt 
with in this short summary. Further de-
tails can be obtained from the book of 
abstracts. 
E. Bone Marrow Transplantation 
Bone marrow transplantation has been 
of great theoretical importance in biology 
because of the insight it gives us on the 
kinetics of stem cells in general and of 
erythroid cells in particular. It has lately 
also assumed considerable practical impor-
tance in the treatment of aplastic ance-
mias, leukcemia, and other states associat-
ed with marrow aplasia (Mathe, ViIlejuif, 
France; van Bekkum, Rijswijk, Nether-
lands). The papers presented at this Con-
gress dealt with some aspects of the 
kinetics of bone marrow transplantation, 
and with the control of the secondary 
syndrome. 
1. Kinetics 
The ability of the bone marrow to 
produce colonies of cells in the spleen of 
whole body irradiated recipient mice (as 
described originally by Till and McCul-
loch, 1961) has been extensively used in 
animal experimentation. The identity of 
the colony forming unit (CFU) is unknown. 
Barnes et al. (Harwell, England) studied 
the fate of the fcetal liver cells injected 
into irradiated recipients and found that 
a percentage of small lymphocytes do 
contribute temporarily to the marrow po-
pUlation by 14-21 days. It was suggested 
that the proliferation of bone marrow was 
proportional to the lymphocyte content. 
Micklem and Ford (Harwell, England) 
found that fcetal hcemopoietic cells pro-
liferated faster than adult cells when in-
jected into suitable recipients. 
2. Control of Secondary Syndrome 
Animals that are given doses of whole 
body radiation that are otherwise lethal, 
can survive if given bone marrow cells. 
Although recovery from radiation occurs, 
the animals can die from what is called 
"secondary syndrome" if allogeneic or 
homologous bone marrow had been used. 
This is a disease associated with aplasia 
of lymphoid tissue, depletion of rapidly 
dividing tissues, e.g. bone marrow, intes-
tine and skin, severe wasting and finally 
death in a few weeks. This syndrome can 
occur whenever immunologically compe-
tent cells (ICC) from lymphoid organs, 
bone marrow, peripheral .blood, etc. are 
injected in sufficient numbers into suit-
able recipients, and it is equivalent to the 
graft-versus-host disease. It was calcul-
ated by van Bekkum (Rijswijk, Nether-
lands) that in the human, secondary syn-
drome can occur by the intra-venous in-
jection of as little as 500 ml of fresh blood 
in the adult (and only 25 ml of blood in 
the newborn) or 3 x 107 bone marrow 
cells/kg body weight, or 3 x 108 liver cells. 
It is important to realise that normally 
such allogeneic cells are rejected and only 
in special cases, when the immune res-
ponse of these recipients is depressed (e.g. 
after relative high doses of whole body 
radiation, alkylating or other cytotoxic 
agents ,or in certain rare disorders of the 
immune system such as the Swiss type 
of alpha-gamma globulinremia, and here-
ditary ataxia telengiectasia), can these 
cells "take" and produce secondary syn-
drome. 
The experiments described at this 
Congress dealt with the control of Secon-
dary syndrome in animals other than man. 
Congdon et a!. (Chicago, USA) observed 
that hypoxic animals given bone marrow 
survived better than normal animals (after 
irradiation), indicating that stem cells in 
the bone marrow can differentiate into 
erythroid precursors rather than into 
immunologic ally competent cells under 
the hypoxic stimulus. Ledney and van 
Bekkum (Rijswijk, Netherlands) observed 
that anti lymphocytic serum (ALS) was of 
little value in preventing graft-versus-host 
disease in the mouse if it is given after 
the immunocompetent cells. A striking 
suppression of the secondary syndrome 
was however observed by treating donor 
mice with ALS prior to innoculating their 
spleen cells into irradiated recipients. In 
the monkey (Balner et al., Rijswijk, Nether-
lands) ALS was proved capable of pro-
longing skin grafts. In some respects there-
fore, the effect of ALS is dependent on the 
species used: it is very effective in mice 
if given to the donors, while in the monkey, 
it is more effective if given to the reci-
pients. 
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The control of the Secondary syn-
drome, at present only a laboratory dis-
ease can be expected to play a much more 
important role in the future when the 
agents mentioned above are used more 
extensively in the treatment of malignant 
conditions as well as in transplantation 
procedures. 
F. Cancer as Homograft 
The search for antigens specific to 
cancer was discussed by Sjogren (Stock-
holm, Sweden). A colony inhibition in vitro 
technique was described and he concluded 
that tumours of viral origin in different 
species had specific cross-reacting trans-
plantation antigens. These results suggest 
that the specific transplantation antigens 
are produced under the direction of the 
virus genome - a conclusion supported 
by the findings of Bonneau et al. (Marseille, 
France). McKhann and Harder (Boston, 
USA) used an indirect isotope labelling 
antibody technique to demonstrate the 
presence of tumour specific antigens on 
cells of virus-induced lymphomas, polyo-
ma-induced sarcoma and methylcholan-
threne induced sarcoma in isologous mice. 
The curious relationship between nor-
mal and malignant trophoplast and the 
host was discussed by Currie and Bag-
shawe (London, England) who found that 
both normal and malignant trophoblast 
are antigenic to their respective host 
lymphocytes. Failure to reject either pre-
gnancy or choriocarcinoma (both being 
antigen-containing allografts) suggests 
that there is some mechanism preventing 
their recognition by lymphocytes. It was 
suggested that "fibrinoid" material (con-
sisting of muco-protein and sialic acid) 
might produce an electro-chemical barrier 
which prevents close contact between 
trophoblast and host lymphocytes. 
That the host can at times reject a 
tumour was indicated from the studies of 
Hall et a!. (London, England). Lympho-
cytes obtained from lymp nodes of sheep 
draining the area of transplatation of rat 
fibrosarcoma, as well as RNA derived from 
these cells produced a "dramatic albeit 
temporary regression of the tumour" when 
injected back into the host - an action 
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which was found to be specific. 
That these experimental studies have 
some bearing on the clinical problem was 
demonstrated by Schwarzenberg and 
Mathe (Villejuif, France). They showed 
that allogeneic bone marrow transferred 
to whole body irradiated patients suffer-
ing from acute leukcemia produced com-
plete remission in four patients. Transfer 
of white blood cells resulted in remission 
in 10/21 patients with acute leukcemia. 
Regression of pleural and ascitic fluid was 
obtained after the local injection of 
heterologous lymphocytes immunised 
against the tumour. 
Although it is too early to be op-
timistic about these new lines of treat-
ment, it can be seen that an immunological 
attack against cancer is possible, and some 
progress has been made in recognising 
antigenic sites on the tumour which are 
lacking in the host; in the preparation of 
lymphoid cells or fractions thereof (e.g. 
RNA) that are capable of attacking the 
tumour cells and thus help the host to 
reject the tumour; and finally, in the use 
of graft-versus-host reaction employing 
allogeneic lymphoid cells to enhance re-
jection of tumour. These and similar me-
thods can be useful adjuncts to radio- or 
chemo-therapy. 
G. Conclusion 
The rapid rate of expansion in the 
field of transplantation witnessed in the 
last few years can be confidently expected 
to continue. New techniques of organ 
transplantation, new concepts in the anti-
genic structure of cells, new methods of 
purifying subcellular fraction of anti-
lymphocytic serum, new drugs to combat 
rejection phenomena, and above all a 
fresh outlook on the mode of action of 
these drugs at a molecular level, will 
doubtless render this an exciting new ap-
proach to biology in general and to clinical 
problems in particular. 
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Coagulation defects are only rarely 
met with in obstetrics. It is probable that 
the complication is nowadays oemg 
diagnosed with increasing frequency, 
owing mainly to a greater awareness of 
the condition. In Mulago Hospital where 
the author practises, it occurred 11 times 
in about 33,500 deliveries in the period 
1964-66. This gives an incidence of about 
0.03%. In cases of concealed accidental 
hcemorrhage the incidence is however 
higher; it appears to occur in some 5% 
of cases. 
Historical background 
The first reported case dates back to 
1901 when De Lee (1901) described death 
in a patient from post partum hcemorrhage 
as being clue to a "Hcemophilia-like phe-
nomenon" which followed concealed acci-
dental hcemorrhage. In 1936 Dieckmann 
(1936) was the first to suggest that wch 
bleeding might be caused by a marked 
